The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma

Neoplasma

Volumn 59, Issue 1, 2012, Pages 52-61

  Huang, C ^a,d   Huang, R ^b   Chang, W ^c   Jiang, T ^a   Huang, K ^a   Cao, J ^a   Sun, X ^a   Qiu, Z ^a,d  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^d Shanghai Key Laboratory of Pancreas Disease   (China)

Author keywords

Angiogenesis; Pancreatic adenocarcinoma; pSTAT3; VEGF; VEGF C

Indexed keywords

STAT3 PROTEIN; VASCULOTROPIN; VASCULOTROPIN C; STAT3 PROTEIN, HUMAN; TUMOR PROTEIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN; VEGFC PROTEIN, HUMAN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANCREAS ADENOCARCINOMA; PROTEIN EXPRESSION; TUMOR VOLUME; ADENOCARCINOMA; BIOSYNTHESIS; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; METASTASIS; MICROVASCULATURE; MIDDLE AGED; MOLECULARLY TARGETED THERAPY; NEOVASCULARIZATION (PATHOLOGY); PANCREAS TUMOR; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MICROVESSELS; MIDDLE AGED; MOLECULAR TARGETED THERAPY; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROPORTIONAL HAZARDS MODELS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUMOR BURDEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84863768572     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2012_007     Document Type: Article

References (19)

1. AKIRA S, NISHIO Y, INOUE M, WANG XJ, WEI S et al. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell. 1994; 77: 63-71. http://dx.doi. org/10.1016/0092-8674(94)90235-6
2. SCHINDLER C, LEVY DE, DECKER T JAK-STAT Signaling: From Interferons to Cytokines. J. Biol. Chem. 2007; 282: 20059-63. http://dx.doi.org/10.1074/jbc.R700016200
3. QIU ZJ, HUANG C, SUN J, QIU W, ZHANG JF, LI HM, JIANG T, HUANG KJ, CAO J RNA interference-mediated signal transducers and activators of transcription 3 gene silencing inhibits invasion and metastasis of human pancreatic cancer cells. Cancer Sci 2007; 98:1099-1106. http://dx.doi. org/10.1111/j.1349-7006.2007.00485.x
4. HUANG C, JIANG T, ZHU L, LIU J, CAO J et al. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo. Int J Oncol 2011;38:1637-1644.
5. YU H, JOVE R The Stats of Cancer-New Molecular Targets Come of Age. Nat. Rev. Cancer. 2004; 4: 97-105. http://dx.doi. org/10.1038/nrc1275
6. HUANG C, CAO J, HUANG KJ, ZHANG F, JIANG T et al. Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cell in vitro. Cancer Science. 2006; 97:1417-1423. http://dx.doi.org/10.1111/j.1349-7006.2006.00340.x
7. KARKKAINEN MJ, PETROVA TV Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene. 2000; 19: 5598-605. http://dx.doi.org/10.1038/sj.onc.1203855
8. CAMPBELL CL, JIANG Z, SAVARESE DMF, SAVARESE TM Increased Expression of the Interleukin-11 Receptor and Evidence of STAT3 Activation in Prostate Carcinoma. Am. J. Pathol. 2001; 158: 25-32. http://dx.doi.org/10.1016/S0002-9440(10)63940-5
9. FUNAMOTO M, FUJIO Y, KUNISADA K, NEGORO S, TONE E et al. Signal Transducer and Activator of Transcription 3 Is Required for Glycoprotein 130-mediated Induction of Vascular Endothelial Growth Factor in Cardiac Myocytes. J. Biol. Chem. 2000; 275: 10561-6. http://dx.doi.org/10.1074/jbc.275.14.10561
10. WEI D, LE X, ZHENG L, WANG L, FREY JA et al. Stat3 Activation Regulates The Expression of Vascular Endothelial Growth Factor And Human Pancreatic Cancer Angiogenesis And Metastasis. Oncogene. 2003; 22: 319-29. http://dx.doi. org/10.1038/sj.onc.1206122
11. JUNG JE, LEE HG, CHO IH, CHUNG DH, YOON SH et al. STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J. 2005; 19: 1296-8.
12. NIU G, BRIGGS J, DENG J, MA Y, LEE H et al. Signal Transducer and Activator of Transcription 3 Is Required for Hypoxia-Inducible Factor-1A RNA Expression in Both Tumor Cells and Tumor-Associated Myeloid Cells. Mol. Cancer Res. 2008; 6: 1099-105. http://dx.doi.org/10.1158/1541-7786.MCR-07-2177
13. NIU G, WRIGHT KL, HUANG M, SONG L, HAURA E et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene. 2002; 21: 2000-8. http://dx.doi.org/10.1038/sj.onc.1205260
14. GRAY MJ, ZHANG J, ELLIS LM, SEMENZA GL, EVANS DB et al. HIF-1a, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Srcdependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene. 2005; 24: 3110-20. http://dx.doi.org/10.1038/sj.onc.1208513
15. KABASHIMA A, MAEHARA Y, KAKEJI Y Overexpression of vascular endothelial growth factor C is related to lymphogenous matastasis in early gastric carcinima. Oncology. 2001; 60: 146-50. http://dx.doi.org/10.1159/000055312
16. TSAI PW, SHIAH SG, LIN MT Up-regulation of vascular growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear-kappa B signaling pathway. J Biol Chem. 2003; 278: 5750-9. http://dx.doi.org/10.1074/jbc. M204863200
17. LEE J, KANG WK, PARK JO, PARK SH, PARK YS et al. Expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Clinical Outcome in Gastric Adenocarcinoma. APMIS. 2009; 117: 598-606. http://dx.doi. org/10.1111/j.1600-0463.2009.02512.x
18. SHEEN-CHEN SM, HUANG CC, TANG PR, CHOU FF, ENG HL Prognostic Value of Signal Transducers and Activators of Transcription 3 in Breast Cancer. Cancer Epidemiology, Biomarks & Prevention. 2008; 17: 2286-90. http://dx.doi. org/10.1158/1055-9965.EPI-08-0089
19. TAKEMOTO S, USHIJIMA K, KAWANO K, YAMAGUCHI T, TERADA A et al. Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma. British Journal of Cancer. 2009; 101: 967-72. http://dx.doi.org/10.1038/sj.bjc.6605212